Elevated GP73 expression is not only observed in acute hepatitis and during the progression of liver disease to cirrhosis6, but also in many cancers including lung cancer7, hepatocellular carcinoma (HCC)2, gastric cancer8, and prostate cancer9. The gene discussed is GOLM1; the disease is cancer.